SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT
                         Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934


        Date of Report (Date of earliest event reported): October 3, 2000


                          CELLEGY PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)


                                   California
             ------------------------------------------------------
                 (State or other jurisdiction of incorporation)



         0-26372                                           82-0429727
----------------------------                          --------------------------
       (Commission                                       (IRS Employer
       File Number)                                      Identification No.)


        349 Oyster Point Boulevard, Suite 200
                South San Francisco, CA                        94080
----------------------------------------------------- --------------------------
        (Address of principal executive offices)             (Zip Code)


                                 (650) 616-2200
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)


--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)







ITEM 5:  OTHER EVENTS.

         Filed with this report as Exhibit  99.01 is a press  release  issued by
the Registrant on October 3, 2000, announcing:

         o    On October 3, 2000, Cellegy Pharmaceuticals,  Inc. (the "Company")
              announced the issuance of 1,500,000 shares of the Company's Common
              Stock in a private  placement  transaction.  Cellegy has agreed to
              file a  registration  statement  covering the resale of the shares
              issued in the transaction.



ITEM 7:  FINANCIAL STATEMENTS AND EXHIBITS.

         (c) Exhibits.

             99.01    Press Release issued by the Registrant on October 3, 2000.






                                       2




                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.




Date: October 5, 2000             CELLEGY PHARMACEUTICALS, INC.


                                  By: /s/ K. MICHAEL FORREST
                                      ------------------------------------------
                                      K. Michael Forrest
                                      President and Chief Executive Officer



                                       3